chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Falling asleep; Feeling extremely weak; Dizziness; Does not feel good; Nausea; Vomiting; stomach pain post vaccination; Burping a lot; Difficulty Urination; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Falling asleep), ASTHENIA (Feeling extremely weak), DIZZINESS (Dizziness), VACCINATION COMPLICATION (Does not feel good) and NAUSEA (Nausea) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.  Concurrent medical conditions included Diabetes and Sulfonamide allergy. Concomitant products included INSULIN and INSULIN DEGLUDEC (TRESIBA) for Diabetes, HYDROXYCHLOROQUINE SULFATE (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]), LEVOTHYROXINE SODIUM (SYNTHROID) and METOPROLOL for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 04-Feb-2021, the patient experienced SOMNOLENCE (Falling asleep), ASTHENIA (Feeling extremely weak), DIZZINESS (Dizziness), VACCINATION COMPLICATION (Does not feel good), NAUSEA (Nausea), VOMITING (Vomiting), ABDOMINAL PAIN UPPER (stomach pain post vaccination), ERUCTATION (Burping a lot) and DYSURIA (Difficulty Urination).   On 06-Feb-2021, SOMNOLENCE (Falling asleep), ASTHENIA (Feeling extremely weak), DIZZINESS (Dizziness), VACCINATION COMPLICATION (Does not feel good), NAUSEA (Nausea), VOMITING (Vomiting), ABDOMINAL PAIN UPPER (stomach pain post vaccination), ERUCTATION (Burping a lot) and DYSURIA (Difficulty Urination) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
fainted; nausea; left arm began to tingle; dizziness; Broke out in a cold sweat; chills; Lost control of my bladder.; This is a spontaneous report from a contactable consumer (patient).  A 45-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL6269), via an unspecified route of administration in Left arm on 04Feb2021 15:00 (at the age of 45-years-old) at SINGLE DOSE for COVID-19 immunization.  Medical history was reported as none.  There were no concomitant medications. 51 hours after receiving the vaccine, the patient was sitting down watching a film. His left arm began to tingle, and he felt a wave of dizziness and nausea come over him. He stood up, walked a few steps and sat back down. He broke out in a cold sweat, chills, and saw stars. He leaned forward with his head in his hands, and apparently fainted for a moment and lost control of his bladder. All events started on 06Feb2021 06:00 PM. No treatment received for the events. The outcome of the events was recovered in Feb2021. No covid prior vaccination, no Covid tested post vaccination, no known allergies.
Patient was given Tdap BOOSTRIX at 6:20pm along with another friend (patient's friend also received the same shot). They both left after receiving shots (at that moment, they both were normal). At 6:30pm, his friend came back saying patient was not feeling well. I went out to check on patient and found patient with head down on a chair. Patient was still conscious and was able to speak. His face looked pale as if his sugar was very low. He said he felt dizzy and just wanted to pass out. He just sat down and put his head down. I gave patient some Pepsi and water. Patient drank the Pepsi and the water. Throughout the whole time, patient was still able to speak and look up. Patient never passed out. Patient stated he received Tdap shot when he was 12 and he fainted back then. After about 5 minutes, patient threw up some water and he said he immediately felt better. I suspected that Tdap shot brought patient's sugar down which caused him to feel dizzy. I kept patient for another 10 minutes and he felt much better. He was able to speak and walk normally. So patient was back to normal after 15 minutes. I said I would call and check up on him the next and patient agreed. I just spoke to patient today (7/20) and patient stated he felt way better. He stated he should be back to normal at least 90%. Patient stated he felt some soreness in the injecting arm which was normal. Besides that, patient said he felt all good. So after checking on patient today, I found patient to be all normal again.
Breakthrough case admission after 4 vaccines Moderna 2/12/21 Lot# 015M20A;  Moderna 3/12/21 Lot# 010A21A;  Moderna11/1921 Lot# 077C21B; 5/25/22 Lot# 059M21A Moderna
Slight headache the day after booster. Swollen lymph node under left armpit, noticed the day after injection, and lasted for several days.
she experienced fatigue; "couldn't move"; This spontaneous report was received from a 73-year-old female patient who was referring to herself. The patient's concurrent conditions, medical history, concomitant therapies and allergies/drug reactions were not provided.  On an unknown date in January 2022, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, exact dose, site of administration, route of administration, lot #, expiration date were not provided) for prophylaxis.  On unspecified date in January 2022 (it was unclear of the exact timing, but either the day after or the 2nd day after the administration), the patient experienced fatigue and "could not move". This lasted for abut 3/4 of a day before she recovered and felt normal again. The outcome of fatigue and "could not move" was reported as recovered on an unknown date.   The causal relationship between fatigue, "could not move" and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not reported.
No additional AE/PQC; inadvertent non-simultaneous administration of MMR-II and VARIVAX less than one month apart to a patient.; This spontaneous report was received from a health care professional and refers to a 5-year-old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 28-AUG-2020, the patient was vaccinated with a second dose of measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live (M-M-R II) (dose, route of administration, anatomical location, lot # and expiration date were not provided). On 01-SEP-2020, the patient was also administered with a second dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided). Both vaccines were administered for prophylaxis. The reporter stated that it was inadvertent, non-simultaneous administration of measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live (M-M-R II) and varicella virus vaccine live (Oka/Merck) (VARIVAX) with less than one month apart (inappropriate schedule of vaccine administered). There was no additional adverse event reported.
Developed acute urticaria now 5 months in duration w/prolonged use of prednisone which caused complication; skin has been permanently damaged from hives & cellulitis as result from flu vaccine 97/98.
Received 1st dose Pfizer 3/23/21 1345 Reaction at 1400, hives and itching  Waited total of 30 min with additional monitoring and gave 25mg Benadryl PO
08/23/22 presents to ED for "fall". PMHx of "diabetes, hypertension"
Few minutes after vaccine heavy right side throat/tonsil, right are very sore and painful raising right arm, and headache next day.
Information has been received from a medical assistant concerning 6 unspecified patients of unknown age and gender. Information about concurrent condition, concomitant therapy, drug reactions/allergies and medical history was not provided. On unknown dates, the patients were each vaccinated with a dose of improperly stored VARIVAX (dose and route were unknown, lot # M003440 with expiration date 20-JAN-2018) for prophylaxis. No adverse effect was reported. The vaccines had been exposed under temperature 10.5 Fahrenheit for 1 hour 24 minutes and there was no previous excursion. Data logger was involved. Additional information has been requested.
PATIENT BLED FROM INJECTION SITES NOW IS SEVERLY ANEMIC, HIGH SUSPICION OF INTRACRANIAL BLEED
dizzy; unsteady; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (unsteady) and DIZZINESS (dizzy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced FEELING ABNORMAL (unsteady). On 17-Feb-2021, the patient experienced DIZZINESS (dizzy). At the time of the report, FEELING ABNORMAL (unsteady) and DIZZINESS (dizzy) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  No relevant concomitant medications were reported.  No treatment information provided.
Right arm: red, swollen area about 2 inches in diameter at injection site. warm to touch. Headache: full head: tops, behind eyes, neck, full body fatigue, low grade fever. No treatment/meds taken specifically for this.
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with GARDASIL. Dose, route, lot number and expiration date were not reported. No co-suspect and concomitant therapies were reported. The physician reported that unspecified patients may have received improperly stored GARDASIL exposed to maximum 10C for multiple timeframes (an on unknown date). No adverse effects were reported. This is one of several reports from the same source. Additional information is not expected.
8/3/21 PMHx of HTN, CAD, PE on Coumadin who present with dizziness, headache, nausea without vomiting and SOB 8/16/21 PMH PE on warfarin, CAD, HTN, PNA who presents for worsening SOB; diagnosed with COVID on 8/3
Patient experienced 1 week of cough starting on 7/2 , tested positive for COVID-19 on 7/9 and was admitted to the hospital from Nursing Home - brought in by EMS. Per EMS - patient was on antibiotics at the nursing home. Only received one dose of Pfizer vaccine.
pt vax 6/98 & in 2/11/98 pt exp ``very severe'' chickenpox, pt treated w/Zovirax
Sudden fatigue and chills. By 6:30 bedridden, uncontrollable shaking with chills, body aches and 102.5'F fever. 600 mg Ibuprofen. Slept 9:30pm- 5:30am. Temp 98`F.
For unknown reason (not documented in chart) patient received the first Moderna COVID-19 Vaccine dose on 10/22/21 and the second dose of Moderna COVID-19 Vaccine on 11/12/21 which is earlier than 28 days and outside of the 4-day grace period. There were no adverse events associated with administration of the vaccine. Per CDC guidance, doses inadvertently administered earlier than the grace period should not be repeated.
Pt has experienced elevated temp 99-102 deg off/on since midnight pt obtaining imm 060407; pt. c/o pain in L shoulder; favors the arm will not move; Redness and heat from L shoulder area present mom states have been giving Tylenol elixir every 4 hr ATC since also using ice packs on area. Mom stated went to ER (did not say where) and they told her to go where the pt rec'd imm.
Cough; sore throat; Not wanting to  eat; Pain in my chest.; Chest congestion; Headache; low grade fever; Spent 3weeks sleeping; I spent 3 weeks with fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Pain in my chest.), CHEST DISCOMFORT (Chest congestion), SOMNOLENCE (Spent 3weeks sleeping), COUGH (Cough) and OROPHARYNGEAL PAIN (sore throat) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypothyroidism (autoimmune acquired hypothyroidism) and Food allergy (shrimp allergy).    On 23-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Pain in my chest.), CHEST DISCOMFORT (Chest congestion), SOMNOLENCE (Spent 3weeks sleeping), COUGH (Cough), OROPHARYNGEAL PAIN (sore throat), DECREASED APPETITE (Not wanting to  eat), FATIGUE (I spent 3 weeks with fatigue), HEADACHE (Headache) and PYREXIA (low grade fever). At the time of the report, CHEST PAIN (Pain in my chest.), DECREASED APPETITE (Not wanting to  eat), FATIGUE (I spent 3 weeks with fatigue) and HEADACHE (Headache) had not resolved and CHEST DISCOMFORT (Chest congestion), SOMNOLENCE (Spent 3weeks sleeping), COUGH (Cough), OROPHARYNGEAL PAIN (sore throat) and PYREXIA (low grade fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter. Treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Live followup received, event decreased appetite and spent 3 weeks sleeping, updated.
arm soreness; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th January 2019, the patient received Shingrix. On 8th January 2019, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. A patient experienced arm soreness after a Shingrix injection. The reporter did not consent to follow-up. Sister of patient was the reporter.
pt recvd vax; devel inject site rxn of erythema w/ a hive in the ctr (flare & wheal rxn);observed by MD for 1 hr; no oth sxs;fever of 101 but resolved next day;inj site rxn dec
I had loose bowels for 2 days it wasn't very strong so I tried Imodium and it went away it was gone. If it would have continued I would have gone to the doctor
1509 Patient stated she felt like her throat was getting tight. Patient was escorted to the exam room and assisted to the table. Patient stated her throat  was getting tighter.  1512  .3mg of epi IM was administered to the right thigh. BP 130/94 pulse 101, resp. 16.  1518 EMS arrived and took over care after report was given.
swelling started July 19; pain started July 7; 4 blood clots in left leg; This is a spontaneous report from a contactable consumer (the patient). A 60-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in Arm Left on 26May2021 13:00 at age of 60-year-old at single dose for COVID-19 immunisation, the patient also received the second dose of other unspecified Pfizer vaccine on 26May2021 in Arm Left. Medical history was none. Perfect health. No known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had been tested for COVID-19 since the vaccination. There was no concomitant medication (the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, the patient did not receive other medications within 2 weeks of vaccination). The patient experienced 4 blood clots in left leg on 07Jul2021, pain started 07Jul2021, swelling started 19Jul2021, spread then went to ER on August 8. They were shocked that there were FOUR. He have ZERO risk factors for blood clots. Perfect health, active, perfect blood work. Said blood clots don't occur with people with no risk factors, and definitely not four. The events resulted in Emergency room/department or urgent care, Life threatening illness(immediate risk of death from the event). Treatment was received for "4 blood clots in left leg", the patient was still on clot dissolving medication. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
32 hours after injection, left arm became sore, red, warm and began to swell.  By 08/24 all signs and symptoms were more pronounced and all of left arm swollen.  Took Motrin and Allegra.  08/26 PM: All signs and symptoms subsiding.
6 hours post vaccine, patient complained of dizziness and if room was spinning. Denied associated clinical manifestional.  Took a 2 hour nap and felt better.   No lost time from work.
I woke up the morning after my second dose experiencing  the common symptoms related to the vaccine -- persistent headache, body ache, fever, cold shivers, and fatigue. These symptoms lasted for approximately 24 hours, and I continued to have a headache for a total of approximately 48 hours.   However, I then developed pain in my left calf approximately 10 days after the second dose and on three consecutive evenings at approximately 9pm I developed an all-body itchy rash (big red raised welts) that would disappear by the time I woke up the next morning. The rash only occurred on these three evenings, but the pain in my calf persisted. I went to see my primary care doctor the following Monday (05/17/21) who gave me a referral for an ultrasound to rule out a DVT, although he said that it was not urgent that I go as I didn't have the other regular symptoms of a DVT (swelling, redness, warm to the touch) and I was too young and healthy to be at risk for one. My doctor said that if the pain didn't subside by the end of the week I should go for the ultrasound. The pain got worse and so I went for an ultrasound on Saturday (05/22/2021). I WAS SUBSEQUENTLY DIAGNOSED WITH A BLOOD CLOT (DVT), and sent to the emergency department.
Patient called on 7/7/19 10:15 am to report symptoms of headache, hives, nausea, and chills persisting for 2 days after vaccination with the Shingrix. Symptoms have resolved some after 2 days, but patient still wanted to have the reaction reported.
Overall body pain onset at 10:30pm thru 9am next day. Fever at 104. Chills. Shivering. No appetite. Unable to sleep. Headache. Experienced these symptoms thru mid day the next day. Fatigue the following day.
pt got sore arm, swelling,  felt warm, had to go to dr office to get antibiotic, dr says arm was infected
couldn't walk /having trouble with stairs and stuff; having trouble with stairs and stuff; weak; nauseous; couldn't eat; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): LRN4527027 (Genentech).  A 50 year-old female patient received bnt162b2 (BNT162B2), administration date 07Mar2021 (Batch/Lot number: unknown) at the age of 49 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Multiple sclerosis" (ongoing), notes: Patient's concurrent condition included: Multiple sclerosis. Concomitant medication(s) included: OCREVUS. The following information was reported: GAIT INABILITY (non-serious), outcome "unknown", described as "couldn't walk /having trouble with stairs and stuff"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious), outcome "unknown", described as "having trouble with stairs and stuff"; ASTHENIA (non-serious), outcome "unknown", described as "weak"; NAUSEA (non-serious), outcome "unknown", described as "nauseous"; FEEDING DISORDER (non-serious), outcome "unknown", described as "couldn't eat".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
crying p/shots standing beside mother;suddenly became very pale, head fell back, eyes rolled up & back then slumped forward;was placed on floor;BP 100/70;cool cloth applied to face;woke up right away & called for mom;sl pale;
It cause me to have three blisters on my left shoulder. When I remove the band-aid , I notice that my pieces of my skin were removed as well. There was still one blister that had not burst yet. The other two had bursted leaving me to have an open sore as though someone had burned my skin. I immediately contacted the facility that administered the shot to me. They then advised me to go to the nearest Urgent care for treatment. Upon my arrival, treated me for the scaring from the Moderna injection.  provided with an oniment to be applied daily until the sore/blister is healed.
CHILD WAS OBSERVED BY PARENT HAVING A SEIZURE TEMP OF 104.5 REPORTED BY PARENT AND TOOK TO ER TO BE CHECKED OUT CHILD DID HAVE PREVIOUS FEBRILE SEIZURE PRIOR TO IMMUNIZATIONS
Starting the night of receiving the vaccine, I had a fever x 2 days. Also, I had liquid diarrhea for 2 months and abdominal pain. I messaged my doctor and symptomatically treated myself.
Patient developed rash on hands that spread to rest of body starting the night after receiving her Pfizer COVID-19 booster. Patient presented to ED and was given prednisone, diphenhydramine, and famotidine. Patients symptoms improved and was discharged with a prescription for prednisone and loratadine
Migraine; runny nose; This is a spontaneous report from a contactable consumer (patient). A 42-years-old female patient received first dose of bnt162b2 BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 01Apr2021 09:45 at SINGLE DOSE for covid-19 immunisation.  The patient was not Pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient medical history was not reported. Concomitant medication received within 2 weeks of vaccination included naproxen sodium (ALEVE). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced Migraine and runny nose on 01Apr2021 13:00. The outcome was recovering.  The patient received Immitrex as treatment.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.